{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:36:45Z","timestamp":1775032605032,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["17K08279"],"award-info":[{"award-number":["17K08279"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["18K08121"],"award-info":[{"award-number":["18K08121"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["19K16396"],"award-info":[{"award-number":["19K16396"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jphs.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T04:00:59Z","timestamp":1625544059000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes"],"prefix":"10.1016","volume":"147","author":[{"given":"Yoichi","family":"Sunagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Funamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Nurmila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Katanasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ehf2.12005","article-title":"Heart failure: preventing disease and death worldwide","volume":"1","author":"Ponikowski","year":"2014","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jphs.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals. Epidemiology of cardiovascular disease in young individuals","volume":"15","author":"Andersson","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jphs.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0735-1097(92)90033-J","article-title":"Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis","volume":"20","author":"Jacoby","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jphs.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/1995-705X.151084","article-title":"Tight glycemic control and cardiovascular effects in type 2 diabetic patients","volume":"15","author":"Moodahadu","year":"2014","journal-title":"Heart Views"},{"key":"10.1016\/j.jphs.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.RES.0000020201.44772.67","article-title":"Cardiomyocyte cell cycle regulation","volume":"90","author":"Pasumarthi","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1253\/circj.CJ-16-0062","article-title":"From left ventricular hypertrophy to dysfunction and failure","volume":"80","author":"Lazzeroni","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jphs.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","article-title":"Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload","volume":"131","author":"Schiattarella","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/MCB.23.10.3593-3606.2003","article-title":"Cardiac p300 is involved in myocyte growth with decompensated heart failure","volume":"23","author":"Yanazume","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jphs.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCULATIONAHA.105.585182","article-title":"Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in\u00a0vivo","volume":"113","author":"Miyamoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1024132217870","article-title":"Biological role of p300 in cardiac myocytes","volume":"248","author":"Yanazume","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jphs.2021.07.001_bib12","first-page":"868","article-title":"The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats","volume":"118","author":"Morimoto","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jphs.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1253\/circj.CJ-09-1012","article-title":"Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin","volume":"74","author":"Morimoto","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jphs.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1016\/S1262-3636(03)72785-2","article-title":"Reducing insulin resistance with metformin: the evidence today","volume":"29","author":"Giannarelli","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jphs.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.jphs.2021.07.001_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","article-title":"Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis","volume":"18","author":"Han","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jphs.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbadis.2016.05.006","article-title":"Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4","volume":"1862","author":"Suzuki","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jphs.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1074\/jbc.M109.070458","article-title":"Cyclin-dependent kinase-9 is a component of the p300\/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes","volume":"285","author":"Sunagawa","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/ijms22041771","article-title":"Histone acetylation domains are differentially induced during development of heart failure in dahl salt-sensitive rats","volume":"22","author":"Funamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1038\/s41598-020-64207-w","article-title":"The synthetic curcumin analogue GO-Y030 effectively suppresses the development of pressure overload-induced heart failure in mice","volume":"10","author":"Shimizu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1055\/a-1191-7970","article-title":"Cacao bean polyphenols inhibit cardiac hypertrophy and systolic dysfunction in pressure overload-induced heart failure model mice","volume":"86","author":"Sari","year":"2020","journal-title":"Planta Med"},{"key":"10.1016\/j.jphs.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jphs.2017.12.013","article-title":"Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes","volume":"136","author":"Sunagawa","year":"2018","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Bowers","year":"2010","journal-title":"Chem Biol"},{"key":"10.1016\/j.jphs.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators of histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jphs.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.celrep.2013.07.047","article-title":"Selective small molecule targeting beta-catenin function discovered by in\u00a0vivo chemical genetic screen","volume":"4","author":"Hao","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.jphs.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3390\/ijms19102869","article-title":"Metabolic effects of metformin in the failing heart","volume":"19","author":"Dziubak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1474-9726.2010.00586.x","article-title":"AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction","volume":"9","author":"Turdi","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.jphs.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gundewar","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.113.02619","article-title":"Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase alpha2","volume":"63","author":"Xu","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jphs.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.metabol.2016.06.011","article-title":"Activation of the AMPK\/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans","volume":"65","author":"Banerjee","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jphs.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","article-title":"Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis","volume":"145","author":"Mihaylova","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jphs.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jphs.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dom.12021","article-title":"Metformin directly inhibits ghrelin secretion through AMP-activated protein kinase in rat primary gastric cells","volume":"15","author":"Gagnon","year":"2013","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jphs.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15171\/apb.2018.008","article-title":"Investigating effect of rapamycin and metformin on angiogenesis in hepatocellular carcinoma cell line","volume":"8","author":"Rastegar","year":"2018","journal-title":"Adv Pharmaceut Bull"},{"key":"10.1016\/j.jphs.2021.07.001_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123721","article-title":"Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response","volume":"10","author":"Sesen","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jphs.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","article-title":"Metformin action: concentrations matter","volume":"21","author":"He","year":"2015","journal-title":"Cell Metabol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:00:54Z","timestamp":1761163254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861321000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1347861321000682"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2021.07.001","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}